Key result
A review of 161 published cases demonstrates that multivessel totally endoscopic coronary artery bypass grafting is feasible and meets open surgery standards, despite higher conversion rates.
Why the study?
Is robotic totally endoscopic multivessel coronary artery bypass grafting feasible and effective compared to open surgery?
Is robotic totally endoscopic multivessel coronary artery bypass grafting feasible and effective compared to open surgery?
Robotic totally endoscopic multivessel CABG is feasible and offers preserved sternum and short recovery, though it is technically demanding with higher conversion rates.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open the role of multivessel totally endoscopic CABG pending randomized data.
Closed-chest totally endoscopic coronary artery bypass grafting (TECAB) is feasible using robotic technology. During the early phases, TECAB was restricted to single bypass grafts to the left anterior descending artery system. Because most patients referred for coronary artery bypass surgery have multivessel disease, development of endoscopic multiple bypass grafting is mandatory. Experimental work on multivessel TECAB was carried out in the early 2000s, and first clinical cases were already performed. With further technological development of operating robots, double, triple, and quadruple TECAB has become feasible both on the arrested heart and on the beating heart. To date, 161 cases of multivessel TECAB using the da Vinci telemanipulation systems are published in the literature. The main advances enabling multivessel TECAB were the availability of a robotic endostabilizer for beating heart procedures and increased surgeon skills using remote access heart-lung machine perfusion and endo-cardioplegia. Both internal mammary arteries can be harvested and both radial artery and vein graft can be used in multivessel TECAB. Y-grafting and sequential grafting are feasible. Multivessel endoscopic surgical revascularization can be combined with percutaneous coronary interventions in advanced hybrid coronary revascularization. Time requirements for multivessel TECAB are significant, and conversion rates to larger thoracic incisions are higher than those observed for single-vessel TECAB. Clinical short- and long-term outcomes, however, seem to meet the standards of open coronary bypass surgery through sternotomy. The main advantages of multivessel TECAB are a completely preserved sternum, use of double internal mammary artery even in risk groups, and a remarkably short recovery time.
No takes yet. Share an insight, caveat, or question.
Bonatti et al. (2012) conducted a review in Multivessel coronary artery disease (n=161). Multivessel totally endoscopic coronary artery bypass grafting (TECAB) vs. Open coronary bypass surgery (historical standard) was evaluated. A review of 161 published cases demonstrates that multivessel totally endoscopic coronary artery bypass grafting is feasible and meets open surgery standards, despite higher conversion rates.
Synapse has enriched 10 related papers. Consider them for comparative context: